MAPK3 and Hyperglycemia: Although ERK1/2 inhibitors can improve insulin gene inhibition induced by chronic hyperglycemia, some studies suggest that they may have no significant effect on insulin secretion under acute glucose stimulation (Panse., 2015; Leduc et al., 2017).